Imunon Inc (FRA:CBO0)
€ 1.31 +0.020 (+1.55%) Market Cap: 5.89 Mil Enterprise Value: 2.53 Mil PE Ratio: 0 PB Ratio: 1.89 GF Score: 26/100

Q2 2026 Imunon Inc Earnings Call Transcript

Aug 11, 2026 / 03:00PM GMT
Operator

Good morning I will be your conference operator for today. At this time, I would like to welcome everyone to the IMUNON second-quarter 2026 financial results and business update conference call. I will now turn the call over to Valter Pinto, Managing Director of Investor Relations at KCSA Strategic Communications for introductions. Please go ahead.

Valter Pinto
KCSA Strategic Communications - Managing Director of Investor Relations

Thank you, operator, and good morning. Welcome to IMUNON second-quarter 2026 financial results and business update conference call. Joining us today are Stacy Lindborg, President and Chief Executive Officer; Dr. Douglas Faller, Chief Medical Officer; and Josh Blacher, Chief Financial Officer. Michael Tardugno, the company's Executive Chairman, is also in the line for the Q&A portion of today's call.

Before we begin, I'd like to remind everyone that our remarks today include forward-looking statements. These statements are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot